The Bahrain Oncology Centre has made medical history by successfully treating a sickle cell disease patient using CRISPR-based gene-editing therapy, Casgevy. This marks the...
Epic’s non-cutting technology to modulate the epigenome advances with the addition of new hypercompact Cas effectors and potent gene activators.
Epic Bio, a biotechnology company...
Origin Agritech Ltd. (the "Company" or "Origin"), an agriculture technology company, announced that it is developing nutritionally enhanced corn using CRISPR technology.
Origin is currently...
